Genocea Biosciences Inc (GNCA) stock is higher by 62.67% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives GNCA stock a score of 66 out of a possible 100.
That rank is primarily influenced by a fundamental score of 92. In addition to the average rating from Wall Street analysts, GNCA stock has a mean target price of 6.48. This means analysts expect the stock to climb 83.57% over the next 12 months. GNCA's rank also includes a long-term technical score of 75. The short-term technical score for GNCA is 31.
What's Happening with GNCA Stock Today
Genocea Biosciences Inc (GNCA) stock is down -3.81% while the S&P 500 is down -0.84% as of 11:20 AM on Thursday, Feb 18. GNCA is down -$0.14 from the previous closing price of $3.67 on volume of 443,644 shares. Over the past year the S&P 500 has risen 15.13% while GNCA is higher by 62.67%. GNCA lost -$0.98 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Genocea Biosciences Inc (GNCA) Stock.
